Loading...
Dernières publications
-
Hélène Bricout, Marie‐cécile Levant, Nada Assi, Pascal Crepey, Alexandre Descamps, et al.. The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-22 influenza season. Clinical Microbiology and Infection, 2024, 30 (12), pp.1592-1598. ⟨10.1016/j.cmi.2024.08.012⟩. ⟨hal-04698967⟩
-
Mathieu Chalouni, Paul Loubet, Edouard Lhomme, Laetitia Ninove, Benoit Barrou, et al.. Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants. BMC Infectious Diseases, 2024, 24 (1), pp.1049. ⟨10.1186/s12879-024-09861-5⟩. ⟨hal-04724620⟩
-
Christine Durier, Laetitia Ninove, Sylvie van der Werf, Maeva Lefebvre, Corinne Desaint, et al.. Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination. Infectious Diseases Now, 2024, 54 (5), pp.104886. ⟨10.1016/j.idnow.2024.104886⟩. ⟨hal-04596145⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
Notices
63
Mots clés
Immunization
ANTIRETROVIRAL THERAPY
Antiviral therapy
Care management
Covid-19
Practices
Antiviral
Delphi study
Antiviral agents
Vaccine hesitancy
Innate immunity
HIV
Incidence
Cohort study
Efficacy
Boys
Vaccination
Sleep
Bayes' theorem
Virology
Coronavirus
Influenza
Dialysis
Older adults
Adults
Vaccine effectiveness
Covid 19
DMD
Confidence
Effectiveness
Specific populations
Acute kidney injury
Conditional marketing authorization
Elderly
CERVICOVAGINAL SECRETIONS
Assay
Attitudes
Booster response
Breakthrough infections
Hesitancy
COVID-19 mRNA vaccine
Cystic fibrosis
Alpha variant
Awareness
Covidom
Attitude
Epidemiology
Diabetes mellitus type 2
Misinformation
Respiratory syncytial virus
Vaccine
Risk factors
Cancer
Adenoviral vector
AIDS
Influenza-like illness
Determinants
Vaccine acceptance
Immunogenicity
Hospitalisations
B-lymphocytes
Vaccines
Deletion
Clinical practice
Co-morbidities
AON
Biomarkers
Attitudes of health personnel
Dendritic cells
COVID-19
Conjugate pneumococcal vaccine
Determinant
Chemotherapy
Antiretroviral therapy
Digital care
COVID-19 vaccines
Internet
AstraZeneca vaccine
Vaccine safety and efficacy
Cost of illness
Clinical research
Adverse effects
Healthcare workers
SARS-CoV-2
Cohort
Catch-up
COCONEL cohort surveys
Attitude to health
Calcium phosphorus evaluation
HPV vaccine
Adjuvant
Chronic kidney disease
Clinical trials
C-type lectin receptor
Clinical skills
Coadministration
Immunocompromised
1790GAHB F
France
Data sharing